Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371850 · ClinicalTrials.gov registry record · Phase 4
Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT02371850 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 10 participants.
The verdict
NCT02371850, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a single-dose, Open-label, Non-Randomized, 2-way Crossover Bioequivalence Study to compare nicotine release after heating of a brand name (Nicoderm CQ) and generic (Aveva skin patch) nicotine skin patches in adult smokers.
Interventions
- DRUG Nicoderm patch first, then Aveva patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371850
The ClinicalTrials.gov registry entry for NCT02371850 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nicoderm patch first, then Aveva patch is the first listed.
NCT02371850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02371850 about?
NCT02371850 is a clinical study titled "Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers". This is a single-dose, Open-label, Non-Randomized, 2-way Crossover Bioequivalence Study to compare nicotine release after heating of a brand name (Nicoderm CQ) and generic (Aveva skin patch) nicotine skin patches in adult smokers.
What is the current status of trial NCT02371850?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2014-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02371850?
The interventions under investigation include: Nicoderm patch first, then Aveva patch (DRUG).
Who is sponsoring clinical trial NCT02371850?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.